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Recent advancement in genomic and genetic 
sequencing technology has ushered in a new 
era in which unprecedented amount of 
genomic sequence and transcript sequence 
data with extraordinary detail can be gener-
ated at incredibly short time. As part of this 
advancement, the approaches that utilize 
the powerful next generation sequencing 
technology, such as RNA-Seq, may have dra-
matically changed the field of non-coding 
RNA (ncRNA) research. Since these new 
approaches do not require prior knowl-
edge of annotated transcripts for probes, 
theoretically the entire transcriptome of a 
given sample can be sequenced. This enables 
the detection of novel transcripts, including 
both protein coding and ncRNA, as well as 
RNA with somatic mutations and alterna-
tive splicing forms (Trapnell et al., 2009, 
2010; Au et al., 2010; Griffith et al., 2010). 
Before this recent technological advance-
ment, in the more traditional approaches for 
ncRNA studies, such as using RNA microar-
ray technology, prior sequence knowledge 
of ncRNA in a cell, tissue, or an organism 
is required to first generate the microarray. 
Known RNA and RNA variants of a sample 
are then hybridized to the array, detected, 
quantified, and analyzed, while unknown 
RNA or RNA variants remain undetected 
and unanalyzed. This is especially limiting 
for the studying of many classes of ncRNA, 
such as long ncRNA (lncRNA, which are 
ncRNA that are longer than 200 nucleo-
tides), due to somatic mutations, epigenetic 
consequences, and the possibility of second-
ary structures that longer RNA often take 
(Wang and Chang, 2011; Mercer et al., 2012; 
Moran et al., 2012). Some additional advan-
tages of RNA-Seq that have been reported 
in studying protein coding transcripts, 
including the capability of detecting high 
dynamic range of gene expression level, and 
its high precision and high  reproducibility 
(Marioni et al., 2008; Mane et al., 2009; 
Bradford et al., 2010; Chen et al., 2010; 
Twine et al., 2011; Zhang et al., 2012), will 
likely further ratify this new trend of ncRNA 
research. Nevertheless, currently microarray 
is still a valid technology for RNA studies 
in many other aspects, for its speed, spe-
cificities for targeted probing, and its low 
cost. For example, since statistically 5% 
of genes give rise to 75% of housekeeping 
transcripts, much effort is required in RNA-
Seq to filter out high abundance transcripts 
before one can piece together and quantify 
the interested lower abundance transcripts 
in a typical RNA sample. Cost is another 
limiting factor for the migration to RNA-
Seq. A typical RNA-Seq run can cost a few 
thousands, while a typical run for a targeted 
high throughput microarray costs around 
hundreds in dollar amount. In the foresee-
able future, microarray and RNA-Seq may 
co-exist and each provides its own aspects 
of advantage.
If the size of human genome truly reflects 
the evolution pressure and practical genomic 
requirements for biological function and 
survival, one may conclude that the num-
ber of genes we have studied and all the facts 
we have discovered on genes and gene regu-
lation is just the tip of an iceberg, because 
merely 1.5–2% of nucleotide (nt) bases in 
the human genome are transcribed into 
genes that code for proteins (Wolfsberg et al., 
2001; The ENCODE Project Consortium, 
2007), which has been the main research 
emphasis for genetic research for the last 
several decades. With the advancement of 
modern technologies, including RNA-Seq 
and microarray technology, it is clear that 
new information on genomes, transcripts, 
and their regulation will increase exponen-
tially in the coming decades (Schulz et al., 
2008; Zerbino et al., 2012). How to manage, 
mine, and  comprehend these large data will 
be a real challenge. Meantime the reward can 
be high and the effort may be well justifi-
able, considering the likely impact the new 
knowledge will have on disease research and 
treatment.
A prominent member of ncRNA in 
brain function and psychiatric disorder is 
microRNA (miRNA), which is believed to 
be the transcripts of 1–3% of the human 
genome. miRNA is highly involved in brain 
development and plasticity at the neuronal 
level (Kapsimali et al., 2007; Choi et al., 
2008; Cheng et al., 2009; Liu et al., 2010; 
Shi et al., 2010; also see reviews by Saba 
and Schratt, 2010; Konopka et al., 2011; Im 
and Kenny, 2012). This ncRNA regulates 
gene expression through RNA interfer-
ence, RNA degradation, DNA methylation, 
and chromatin remodeling. As reviewed 
by two articles in this special issue from 
Kenny and Mains groups, recent discover-
ies of miRNA function and mechanisms 
in cocaine addiction have demonstrated 
important roles of ncRNA in this psychi-
atric disorder. For example, in the dorsal 
striatum, miR-212 was upregulated in rats 
addicted to cocaine and this upregulation 
enhances miR-212 regulated CREB signal-
ing and counters the motivational property 
of cocaine (Hollander et al., 2010). Further 
studies found this specific function of miR-
212 involves its negative homeostatic inter-
action with transition of acquizition period 
of addiction to compulsive-like increase of 
craving of cocaine. The downstream sign-
aling pathway is further revealed in the 
same study to be through the controlling 
of BDNF levels in dorsal striatum (Im et al., 
2010). Corroborative evidence of cocaine 
induced various miRNA expression and 
their functional role in cocaine addiction 
have also emerged in more and more other 
laboratories, complementing many aspects 
of our understanding (Nudelman et al., 
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2010; Schaefer et al., 2010; Chandrasekar 
and Dreyer, 2011; Eipper-Mains et al., 2011). 
Particularly remarkable in one of these 
studies is that, using RNA-Seq approaches, 
cocaine is found to both upregulate and 
downregulate specific miRNA or family of 
miRNA (Eipper-Mains et al., 2011). While 
similar findings have been reported earlier 
in the nervous system (Vo et al., 2005; Krol 
et al., 2010; Nudelman et al., 2010), this 
RNA-Seq study is the first comprehensive 
analysis of cocaine induced changes of 
miRNA, and has demonstrated the advan-
tage of next generation sequencing technol-
ogy over microarray technology, which is 
often weakened by cross hybridization and 
high background signal, and critically lim-
ited by its prerequisite of prior knowledge 
of ncRNA identity it analyzes.
A much less tapped area in ncRNA 
research for the understanding of addic-
tion of cocaine, or other substances of 
abuse, is the lncRNA; Wapinski and Chang, 
2011; Huang et al., 2012; Jeggari et al., 
2012; Moran et al., 2012. lncRNA are those 
ncRNA that are longer than 200 nucleotides 
and are oftentimes transcripts of intergenic 
regions between transcription clusters, or 
“foci,” in the genome. Some earlier projects 
identified around 35,000 long non-coding 
transcripts from estimated 10,000 distinct 
loci in mammalian genome, often bearing 
signatures of protein coding mRNA, such 
as 5′ capping, splicing, and poly adenyla-
tion, but have no apparent open read-
ing frame (ORF) for protein translation 
(Carninci, 2005, 2006; Kapranov et al., 
2010). Remarkably, many more lncRNA 
may exist but not recognized due to the 
fact that the majority of lncRNA tran-
scripts may not be poly adenylated (Cheng 
et al., 2005; Carninci, 2006; Kapranov et al., 
2010), while many of the transcripts detec-
tion approaches rely on first hybridizing 
the poly adenylated region. Functionally, 
lncRNA have been found to have roles 
in epigenetic regulation, imprinting, and 
X-chromosome inactivation, in addition to 
regulation of gene transcription and trans-
lation (Mercer et al., 2009; Wang and Chang, 
2011; Wapinski and Chang, 2011; Harries, 
2012; Huang et al., 2012; Moran et al., 2012). 
Consequently, lncRNA may play signifi-
cant roles in cocaine addiction. Indeed, it 
is likely that future work will identified high 
numbers of lncRNA in brain areas of the 
putative learning-reward-addiction neural 
circuits such as nucleus accumbens, and will 
likely shed light on important involvement 
of lncRNA in these brain regions for reward 
and addiction. How genetic and epigenetic 
factors interact with these lncRNA, and how 
changes were brought upon these lncRNA 
by brain activities, in terms of lncRNA 
mutation, expression level, dynamics, and 
function, may provide significant insights 
on the mechanisms of cocaine addiction. 
Because substance abuse and dependence 
involves substantial gene-environment 
interactions and epigenetic factors, the 
capability of RNA-Seq in detecting novel 
gene variations and de novo gene mutations 
also provides valuable and necessary tools 
for the addiction research field.
The complexity and abundance of 
ncRNA, especially lncRNA, mandate 
advanced non-traditional, large scale and 
high throughput transcript sequencing, 
and analysis. While microarray technology 
enjoys established base and proven utility, 
the next generation sequencing technology 
represented by RNA-Seq emerges as the 
future choice approach for the task because 
of its unbiased coverage of the entire tran-
scriptome of the genome. In addition, RNA-
Seq allows versatile experimental design for 
sequencing depth and adjustable detection 
sensitivity, using machines of different 
throughputs and multiplexing different 
numbers of samples on a sequencing lane. 
Furthermore, the inherited benefit of RNA-
Seq (Mane et al., 2009; Bradford et al., 2010; 
Chen et al., 2011; Eipper-Mains et al., 2011; 
also see reviews in this issue), including low 
background noise, low error rate and low 
technical variance, the high accuracy of the 
digital nature, and the capability of detect-
ing novel transcripts and alternative splic-
ing forms, will definitely benefit not only 
ncRNA analysis, but all other forms of RNA 
research as well. All these will greatly enable 
researchers in the field of substance abuse 
and dependence for future discoveries and 
breakthroughs.
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